fig2

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

Figure 2. A clinical management flowchart for ICI use in LT candidates (created with BioGDP.com). ICI: Immune checkpoint inhibitor; LT: liver transplantation.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/